BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8581873)

  • 21. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Levels of Osteocalcin and Insulin Resistance in Patients with Impaired Glucose Tolerance or New-Onset Diabetes Mellitus After Liver Transplantation.
    Martínez-Díaz-Guerra G; Guadalix S; Aramendi M; Librizzi S; García E; Jiménez C; Hawkins F
    Horm Metab Res; 2016 May; 48(5):325-30. PubMed ID: 26743527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of serum osteocalcin levels with blood glucose, insulin resistance and lipid profile in central Indian men with type 2 diabetes.
    Sarkar PD; Choudhury AB
    Arch Physiol Biochem; 2012 Dec; 118(5):260-4. PubMed ID: 22978420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum osteocalcin in hyperthyroidism].
    Roiter I; Legovini P; Da Rin G; Galliazzo S; Di Virgilio R; Foscolo G; Breda F; Conte N
    Ann Ital Med Int; 1990; 5(2):95-9. PubMed ID: 2248865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term bone loss in insulin-dependent diabetic patients with microvascular complications.
    Mathiassen B; Nielsen S; Johansen JS; Hartwell D; Ditzel J; Rødbro P; Christiansen C
    J Diabet Complications; 1990; 4(4):145-9. PubMed ID: 2151224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marathon running accompanied by transient decreases in urinary calcium and serum osteocalcin levels.
    Malm HT; Ronni-Sivula HM; Viinikka LU; Ylikorkala OR
    Calcif Tissue Int; 1993 Mar; 52(3):209-11. PubMed ID: 8481834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
    Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
    Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lumbar spine bone mineral density in diabetic children with recent onset.
    De Schepper J; Smitz J; Rosseneu S; Bollen P; Louis O
    Horm Res; 1998; 50(4):193-6. PubMed ID: 9838239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
    Hsieh SD; Akanuma Y; Takaku F
    Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM).
    Cha T; Tahara Y; Ikegami H; Fukuda M; Yoneda H; Yamato E; Yamamoto Y; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Sep; 13(3):181-7. PubMed ID: 1959481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolactin and beta-endorphin responses to hypoglycemia are reduced in well-controlled insulin-dependent diabetes mellitus.
    Kinsley BT; Levy CJ; Simonson DC
    Metabolism; 1996 Nov; 45(11):1434-40. PubMed ID: 8931651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low bone mineral density is associated to poor glycemic control and increased OPG expression in children and adolescents with type 1 diabetes.
    Loureiro MB; Ururahy MA; Freire-Neto FP; Oliveira GH; Duarte VM; Luchessi AD; Brandão-Neto J; Hirata RD; Hirata MH; Maciel-Neto JJ; Arrais RF; Almeida MG; Rezende AA
    Diabetes Res Clin Pract; 2014 Mar; 103(3):452-7. PubMed ID: 24529565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus.
    Rosato MT; Schneider SH; Shapses SA
    Calcif Tissue Int; 1998 Aug; 63(2):107-11. PubMed ID: 9685513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyproline excretion is increased in diabetes mellitus and related to the presence of microalbuminuria.
    Selby PL; Shearing PA; Marshall SM
    Diabet Med; 1995 Mar; 12(3):240-3. PubMed ID: 7758261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism.
    Boulet LP; Giguère MC; Milot J; Brown J
    J Allergy Clin Immunol; 1994 Nov; 94(5):796-803. PubMed ID: 7963147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control.
    Mughal MA; Jan M; Maheri WM; Memon MY; Ali M
    J Pak Med Assoc; 2000 Nov; 50(11):381-6. PubMed ID: 11126815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of inhaled corticosteroids and dietary intake on bone density and metabolism in patients with moderate to severe asthma.
    Gagnon L; Boulet LP; Brown J; Desrosiers T
    J Am Diet Assoc; 1997 Dec; 97(12):1401-6. PubMed ID: 9404337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.